Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53

被引:80
作者
Tominaga, K
Morisaki, H
Kaneko, Y
Fujimoto, A
Tanaka, T
Ohtsubo, M
Hirai, M
Okayama, H
Ikeda, K
Nakanishi, M
机构
[1] Nagoya City Univ, Sch Med, Dept Biochem, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Natl Inst Longev Sci, Dept Geriatr Res, Aichi 4748522, Japan
[3] Kurume Univ, Inst Life Sci, Div Mol Genet, Kurume, Fukuoka 8390861, Japan
[4] Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Bunkyo Ku, Tokyo 113, Japan
关键词
D O I
10.1074/jbc.274.44.31463
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In response to DNA damage, mammalian cells adopt checkpoint regulation, by phosphorylation and stabilization of p53, to delay cell cycle progression. However, most cancer cells that lack functional p53 retain an unknown checkpoint mechanism(s) by which cells are arrested at the G(2)/M phase. Here we demonstrate that a human homolog of Cds1/Rad53 kinase (hCds1) is rapidly phosphorylated and activated in response to DNA damage not only in normal cells but in cancer cells lacking functional p53. A survey of various cancer cell lines revealed that the expression level of hCds1 mRNA is inversely related to the presence of functional p53. In addition, transfection of normal human fibroblasts with SV40 T antigen or human papilloma viruses E6 or E7 causes a marked induction of hCds1 mRNA, and the introduction of functional p53 into SV40 T antigen- and E6-, but not E7-, transfected cells decreases the hCds1 level, suggesting that p53 negatively regulates the expression of hCds1. In cells without functional ataxia telangiectasia mutated (ATM) protein, phosphorylation and activation of hCds1 were observed in response to DNA damage induced by UV but not by ionizing irradiation. These results suggest that hCds1 is activated through an ATM-dependent as well as -independent pathway and that it may complement the function of p53 in DNA damage checkpoints in mammalian cells.
引用
收藏
页码:31463 / 31467
页数:5
相关论文
共 47 条
  • [1] Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways
    Barlow, C
    Brown, KD
    Deng, CX
    Tagle, DA
    WynshawBoris, A
    [J]. NATURE GENETICS, 1997, 17 (04) : 453 - 456
  • [2] Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation
    Beamish, H
    Williams, R
    Chen, P
    Lavin, MF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) : 20486 - 20493
  • [3] The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells
    Biggs, JR
    Kudlow, JE
    Kraft, AS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) : 901 - 906
  • [4] A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase
    Blasina, A
    Van de Weyer, I
    Laus, MC
    Luyten, WHML
    Parker, AE
    McGowan, CH
    [J]. CURRENT BIOLOGY, 1999, 9 (01) : 1 - 10
  • [5] Mutations of mitotic checkpoint genes in human cancers
    Cahill, DP
    Lengauer, C
    Yu, J
    Riggins, GJ
    Willson, JKV
    Markowitz, SD
    Kinzler, KW
    Vogelstein, B
    [J]. NATURE, 1998, 392 (6673) : 300 - 303
  • [6] DUTHU A, 1992, ONCOGENE, V7, P2161
  • [7] THE HUMAN PAPILLOMA VIRUS-16 E7-ONCOPROTEIN IS ABLE TO BIND TO THE RETINOBLASTOMA GENE-PRODUCT
    DYSON, N
    HOWLEY, PM
    MUNGER, K
    HARLOW, E
    [J]. SCIENCE, 1989, 243 (4893) : 934 - 937
  • [8] DEFINITION OF A CONSENSUS BINDING-SITE FOR P53
    ELDEIRY, WS
    KERN, SE
    PIETENPOL, JA
    KINZLER, KW
    VOGELSTEIN, B
    [J]. NATURE GENETICS, 1992, 1 (01) : 45 - 49
  • [9] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [10] Cell cycle checkpoints: Preventing an identity crisis
    Elledge, SJ
    [J]. SCIENCE, 1996, 274 (5293) : 1664 - 1672